Sami Totah details RADCOM (RDCM) share and option holdings
Rhea-AI Filing Summary
RADCOM Ltd director Sami Totah filed an initial ownership report showing 24,250 Ordinary Shares held directly, plus share options over 16,000 Ordinary Shares at an exercise price of 10.01 expiring in 2034 and options over 14,213 shares at 11.89 expiring in 2035. Footnotes also describe 3,500 additional Ordinary Shares issuable as restricted share units that vest monthly until October 15, 2026, and confirm the option grant dates and vesting schedules.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Options (right to buy | -- | -- | -- |
| holding | Share Options (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (3)
- F1. Includes a total amount of 3,500 Ordinary Shares issuable upon the vesting of restricted share units on a monthly basis until October 15, 2026.
- F2. The options were granted on October 15, 2024, and vest on a monthly basis, beginning November 15, 2024, until October 15, 2026.
- F3. The options were granted on January 1, 2025, and became fully vested as of February 8, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Sami Totah report owning in RADCOM (RDCM) on this Form 3?
He reports direct ownership of 24,250 Ordinary Shares of RADCOM. In addition, the filing lists vested and unvested equity awards, including share options and restricted share units that together represent further potential Ordinary Shares if fully vested and exercised over time.
What are the vesting terms of Sami Totah’s RADCOM (RDCM) options granted in 2024?
Options granted on October 15, 2024 vest on a monthly basis starting November 15, 2024, continuing until October 15, 2026. These options relate to 16,000 underlying Ordinary Shares exercisable at 10.01, providing a gradual vesting schedule over that period.
What does the Form 3 say about Sami Totah’s 2025 RADCOM (RDCM) option grant?
The filing notes that options granted on January 1, 2025 became fully vested as of February 8, 2026. These options cover 14,213 underlying Ordinary Shares with an exercise price of 11.89 and an expiration date in 2035, all held directly.